CLINICAL AND PARA-CLINICAL CHARACTERISTICS AND RELATED FACTORS OF PREECLAMPSIA IN PREGNANT WOMEN AT HANOI OBSTETRICS AND GYNECOLOGY HOSPITAL IN 2024

Trọng Hưng Mai, Tuấn Đạt Đỗ, Văn Đạt Lê, Hoàng Thành Lương, Thị Thu Trang Đinh, Đồng Long Phạm, Quang Dũng Phạm, Ngọc Chi Mai Nguyễn, Đức Dương Nguyễn, Văn Phương Hồ

Main Article Content

Abstract

Objective: This study aims to investigate the clinical and para-clinical characteristics and some related factors of preeclampsia (PE) at Hanoi Obstetrics and Gynecology Hospital in 2024. Subjects and Methods: A retrospective cross-sectional descriptive study was conducted on 84 pregnant women diagnosed with preeclampsia at Hanoi Obstetrics and Gynecology Hospital from January 1, 2024, to December 31, 2024. Results: The average age of the study group was 31.3 ± 5.8 years, with 75% under 35 years old. Among the participants, 47.6% were primigravida. The most common medical history was gestational diabetes, accounting for 25%. At hospital admission, grade 1 hypertension was the most prevalent, observed in 53.6% of cases. The average urinary protein concentration in the severe PE group was 2.0 g/L, significantly higher than the 0.9 g/L in the non-severe PE group. Laboratory findings showed increases in AST, ALT, uric acid, blood creatinine, and urinary protein, along with decreases in serum albumin and platelet count. At the time of pregnancy termination (PT), 76.2% of women belonged to the severe PE group, while 23.8% were in the non-severe group. Among PE cases, severe hypertension was the most common severe symptom. Conclusion: Hypertension is the primary clinical manifestation, with severe hypertension being the most frequent severe sign. The severe PE group had significantly higher urinary protein levels. There is a correlation between maternal age, parity, and medical history with the occurrence of PE.

Article Details

References

Gestational Hypertension and Preeclampsia: ACOG Practice Bulletin, Number 222. Obstetrics & Gynecology. 2020;135(6):e237-e260.
2. S. Chandrasekaran, R. Simon. Hepatic Complications in Preeclampsia. Clin Obstet Gynecol. Mar 2020;63(1):165-174. doi:10.1097/ GRF.0000000000000501
3. T. M. Le, L. H. Nguyen, N. L. Phan, et al. Maternal serum uric acid concentration and pregnancy outcomes in women with pre-eclampsia/eclampsia. Int J Gynaecol Obstet. Jan 2019;144(1):21-26. doi:10.1002/ijgo.12697
4. B. Sibai, G. Dekker, M. Kupferminc. Pre-eclampsia. Lancet. Feb 26-Mar 4 2005; 365(9461):785-99.
5. Nguyễn Bích Hồng, Ngô Văn Thư. "Đặc điểm lâm sàng, cận lâm sàng và kết quả xử trí sản phụ tiền sản giật tại Bệnh viện Phụ sản Nam Định năm 2023". Tạp chí Y học Việt Nam. 2024;540(2)
6. Hai-Na Zhang, Qiao-Qiao Xu, Abhimanyu Thakur, et al. Endothelial dysfunction in diabetes and hypertension: role of microRNAs and long non-coding RNAs. Life sciences. 2018;213:258-268
7. Cao Thị Hảo. "Kết quả tiền sản giật trong 3 tháng cuối thai kỳ tại bệnh viện Sản nhi Nghệ An trong 2 năm 2021-2022". Luận văn thạc sĩ Y học, 2023
8. E. Rasmark Roepke, O. B. Christiansen, K. Kallen, S. R. Hansson. Women with a History of Recurrent Pregnancy Loss Are a High-Risk Population for Adverse Obstetrical Outcome: A Retrospective Cohort Study. J Clin Med. Jan 6 2021;10(2)
9. Ngô Văn Tài. Tiền sản giật và sản giật. Nhà xuất bản Y học, Hà Nội; 2006.
10. P. Moran, M. D. Lindheimer, J. M. Davison. The renal response to preeclampsia. Semin Nephrol. Nov 2004;24(6):588-95